Bausch + Lomb Corp. (BLCO) shares fell sharply by 5.47% during intraday trading on Wednesday, a significant downturn for the eye health company.
The sell-off followed the company's release of its fourth-quarter financial results before the market opened. Bausch + Lomb reported adjusted earnings per share of $0.32, which missed the analyst consensus estimate of $0.35. This represents a 9.09% earnings miss despite a 1.72% revenue beat, with sales coming in at $1.405 billion against an estimate of $1.381 billion.
Investors appeared to focus on the earnings shortfall, driving the stock price lower. The company also issued its 2026 revenue guidance, projecting a range of $5.38 billion to $5.48 billion, which is largely in line with the FactSet estimate of $5.39 billion.